MiNK Therapeutics Financial Overview
MiNK Therapeutics's market cap is currently $55.86M. The company's EPS TTM is $-0.65; its P/E ratio is -3.94; MiNK Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
